Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2025

Michael O'Riordan

June 30, 2025

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Conference News TCT 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Todd Neale

October 24, 2023

News Daily News

Acute AF Can Recur: Manage and Monitor Long-term, Says AHA

Michael O'Riordan

March 16, 2023

News Daily News

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Michael O'Riordan

March 23, 2022

News Conference News EACTS 2021

TAVI Registries Offer Outcome Clues as Low-Risk Numbers Climb

Shelley Wood

October 20, 2021

News Conference News EACTS 2021

More Deaths With Bioprosthetic Than Mechanical AVR in Young AS Patients

Michael O'Riordan

October 18, 2021

News Daily News

SWEDEHEART Data Reassure on 10-Year Survival for TAVI Patients With Pacemakers

Caitlin E. Cox

October 05, 2021

News Conference News CRT 2021

DOAC Use Increasing in Patients With Bioprosthetic Heart Valves

Todd Neale

March 08, 2021

News CV Team Pro

NorthShore University Health System

L.A. McKeown

December 30, 2020

News Daily News

Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves

Michael O'Riordan

May 27, 2020

News Daily News

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

Michael O'Riordan

August 29, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Shelley Wood

March 11, 2019

News Conference News TCT 2017

A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients

Todd Neale

November 08, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Conference News CRT 2017

Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy

Michael O'Riordan

February 20, 2017

News Features

The Prickly Problem of Permanent Pacing After TAVR: One Hospital Pitches a Protocol

Michael O'Riordan

January 24, 2017

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

Advertisement

What’s Going to Be Hot at TCT 2025

TCTMD’s Top 10 Most Popular Stories for June 2025

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Acute AF Can Recur: Manage and Monitor Long-term, Says AHA

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

TAVI Registries Offer Outcome Clues as Low-Risk Numbers Climb

More Deaths With Bioprosthetic Than Mechanical AVR in Young AS Patients

SWEDEHEART Data Reassure on 10-Year Survival for TAVI Patients With Pacemakers

DOAC Use Increasing in Patients With Bioprosthetic Heart Valves

NorthShore University Health System

Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy

The Prickly Problem of Permanent Pacing After TAVR: One Hospital Pitches a Protocol

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content